Clarius Group, LLC

SEC CIK: 0001664214
Latest filing: Jan 14, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q4 2025 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of ALNY by Clarius Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−1,007−100.0%	Sold out	Holders
Q4 2022	1,007	$239.0K	<0.1%	−20−1.9%	Reduced	Holders
Q3 2022	1,027	$206.0K	<0.1%	+1,027	New	Holders